Cyclooxygenase inhibitors repress vascular hyaluronan-synthesis in murine atherosclerosis and neointimal thickening

Journal of Cellular and Molecular Medicine

Volumn 13, Issue 9 B, 2009, Pages 3713-3719

  Marzoll, Andrea ^a   Nagy, Nadine ^a   Wördehoff, Luisa ^a   Dai, Guang ^a   Fries, Susanne ^b   Lindner, Volkhard ^c   Grosser, Tilo ^b   Fischer, Jens W ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Maine Medical Center Research Institute   (United States)

Author keywords

Atherosclerosis; Cyclooxygenase inhibitors; Extracellular matrix; Hyaluronan; Neointimal hyperplasia; Vascular remodelling

Indexed keywords

APOLIPOPROTEIN E; GLUCURONOSYLTRANSFERASE; HYALURONAN SYNTHASE; HYALURONIC ACID; INDOMETACIN; ISOPROTEIN; LACTONE; PROSTAGLANDIN SYNTHASE INHIBITOR; ROFECOXIB; SULFONE;

ANIMAL; ARTICLE; ATHEROSCLEROSIS; BIOSYNTHESIS; CAROTID ARTERY; DISEASE MODEL; GENETICS; MALE; METABOLISM; MOUSE; NEOINTIMA; PATHOLOGY; TRANSGENIC MOUSE;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CAROTID ARTERIES; CYCLOOXYGENASE INHIBITORS; DISEASE MODELS, ANIMAL; GLUCURONOSYLTRANSFERASE; HYALURONIC ACID; INDOMETHACIN; LACTONES; MALE; MICE; MICE, TRANSGENIC; NEOINTIMA; PROTEIN ISOFORMS; SULFONES;

MURINAE; MUS;

EID: 69949105788     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2009.00736.x     Document Type: Article

References (26)

1. Jiang D, Liang J, Noble PW. Hyaluronan in tissue injury and repair. Annu Rev Cell Dev Biol 2007, 23:435-61.
2. Toole BP. Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer 2004, 4:528-39.
3. Riessen R, Wight TN, Pastore C. Distribution of hyaluronan during extracellular matrix remodeling in human restenotic arteries and balloon-injured rat carotid arteries. Circulation 1996, 93:1141-7.
4. Cuff CA, Kothapalli D, Azonobi I. The adhesion receptor CD44 promotes atherosclerosis by mediating inflammatory cell recruitment and vascular cell activation. J Clin Invest 2001, 108:1031-40.
5. Toole BP, Wight TN, Tammi MI. Hyaluronan-cell interactions in cancer and vascular disease. J Biol Chem 2002, 277:4593-6.
6. Fischer JW, Schrör K. Regulation of hyaluronan synthesis by vasodilatory prostaglandins. Implications for atherosclerosis. Thromb Haemost 2007, 98:287-95.
7. Evanko SP, Johnson PY, Braun KR. Platelet-derived growth factor stimulates the formation of versican-hyaluronan aggregates and pericellular matrix expansion in arterial smooth muscle cells. Arch Biochem Biophys 2001, 394:29-38.
8. Camenisch TD, Spicer AP, Brehm-Gibson T. Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. J Clin Invest 2000, 106:349-60.
9. Sussmann M, Sarbia M, Meyer-Kirchrath J. Induction of hyaluronic acid synthase 2 (HAS2) in human vascular smooth muscle cells by vasodilatory prostaglandins. Circ Res 2004, 94:592-600.
10. van den Boom M, Sarbia M, von Wnuck Lipinski K. Differential regulation of hyaluronic acid synthase isoforms in human saphenous vein smooth muscle cells: possible implications for vein graft stenosis. Circ Res 2006, 98:36-44.
11. Pritchard KA, O'Banion MK, Miano JM. Induction of cyclooxygenase-2 in rat vascular smooth muscle cells in vitro and in vivo. J Biol Chem 1994, 269:8504-9.
12. Funk CD, FitzGerald GA. COX-2 inhibitors and cardiovascular risk. J Cardiovasc Pharmacol 2007, 50:470-9.
13. Kumar A, Lindner V. Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow. Arterioscler Thromb Vasc Biol 1997, 17:2238-44.
14. Dai G, Freudenberger T, Zipper P. Chronic ultraviolet B irradiation causes loss of hyaluronic acid from mouse dermis because of down-regulation of hyaluronic acid synthases. Am J Pathol 2007, 171:1451-61.
15. Rudic RD, Brinster D, Cheng Y. COX-2-derived prostacyclin modulates vascular remodeling. Circ Res 2005, 96:1240-7.
16. Cyrus T, Yao Y, Ding T. Thromboxane receptor blockade improves the antiatherogenic effect of thromboxane A2 suppression in LDLR KO mice. Blood 2007, 109:3291-6.
17. Kobayashi T, Tahara Y, Matsumoto M. Roles of thromboxane A(2) and prostacyclin in the development of atherosclerosis in apoE-deficient mice. J Clin Invest 2004, 114:784-94.
18. Rott D, Zhu J, Burnett MS. Effects of MF-tricyclic, a selective cyclooxygenase-2 inhibitor, on atherosclerosis progression and susceptibility to cytomegalovirus replication in apolipoprotein-E knockout mice. J Am Coll Cardiol 2003, 41:1812-9.
19. Burleigh ME, Babaev VR, Oates JA. Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice. Circulation 2002, 105:1816-23.
20. Pratico D, Tillmann C, Zhang ZB. Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice. Proc Natl Acad Sci USA 2001, 98:3358-63.
21. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993, 362:801-9.
22. Libby P, Schwartz D, Brogi E. A cascade model for restenosis. A special case of atherosclerosis progression. Circulation 1992, 86:III47-52.
23. Saavalainen K, Pasonen-Seppanen S, Dunlop TW. The human hyaluronan synthase 2 gene is a primary retinoic acid and epidermal growth factor responding gene. J Biol Chem 2005, 280:14636-44.
24. Samuel SK, Hurta RA, Spearman MA. TGF-beta 1 stimulation of cell locomotion utilizes the hyaluronan receptor RHAMM and hyaluronan. J Cell Biol 1993, 123:749-58.
25. Yang T, Huang YG, Ye W. Influence of genetic background and gender on hypertension and renal failure in COX-2-deficient mice. Am J Physiol Renal Physiol 2005, 288:F1125-32.
26. Chai S, Chai Q, Danielsen CC. Overexpression of hyaluronan in the tunica media promotes the development of atherosclerosis. Circ Res 2005, 96:583-91.